About: 1996 National Heart Foundation clinical guidelines for the assessment and management of dyslipidaemia. Dyslipidaemia Advisory Group on behalf of the scientific committee of the National Heart Foundation of New Zealand

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: 1996 National Heart Foundation clinical guidelines for the assessment and management of dyslipidaemia. Dyslipidaemia Advisory Group on behalf of the scientific committee of the National Heart Foundation of New Zealand Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 June 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 1996 (uk) article scientifique publié en 1996 (fr) im Juni 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunu de 1996 (ast) scientific article published on 01 June 1996 (en)
publication date	wds:Q71433378-A809DC96-FB7C-48AC-AAC2-10FF0D799BE0
publication date	1996-06-01 00:00:00Z (xsd:dateTime)
rdfs:label	1996 National Heart Foundation clinical guidelines for the assessment and management of dyslipidaemia. Dyslipidaemia Advisory Group on behalf of the scientific committee of the National Heart Foundation of New Zealand (en) 1996 National Heart Foundation clinical guidelines for the assessment and management of dyslipidaemia. Dyslipidaemia Advisory Group on behalf of the scientific committee of the National Heart Foundation of New Zealand (nl)
skos:prefLabel	1996 National Heart Foundation clinical guidelines for the assessment and management of dyslipidaemia. Dyslipidaemia Advisory Group on behalf of the scientific committee of the National Heart Foundation of New Zealand (en) 1996 National Heart Foundation clinical guidelines for the assessment and management of dyslipidaemia. Dyslipidaemia Advisory Group on behalf of the scientific committee of the National Heart Foundation of New Zealand (nl)
name	1996 National Heart Foundation clinical guidelines for the assessment and management of dyslipidaemia. Dyslipidaemia Advisory Group on behalf of the scientific committee of the National Heart Foundation of New Zealand (en) 1996 National Heart Foundation clinical guidelines for the assessment and management of dyslipidaemia. Dyslipidaemia Advisory Group on behalf of the scientific committee of the National Heart Foundation of New Zealand (nl)
title	wds:Q71433378-79FB4E2A-4ABC-4D66-882E-46D2DA384F3D
title	1996 National Heart Foundation clinical guidelines for the assessment and management of dyslipidaemia. Dyslipidaemia Advisory Group on behalf of the scientific committee of the National Heart Foundation of New Zealand (en)
page(s)	wds:Q71433378-0574651F-91EE-412A-83AE-4FA59A002E92
page(s)	224-231
instance of	wds:Q71433378-5C9FBBFC-A74D-4E64-A516-887C8AE14A95
instance of	scholarly article
main subject	wds:Q71433378-25CE3D62-D5B8-4BD4-A7E1-1D1355905BF1 wds:Q71433378-41F4ED9E-7D41-4753-BF06-906FFA21DB53
main subject	New Zealand dyslipidemias
PubMed ID	wds:Q71433378-42FDBD6B-31EF-407B-B21C-89B9510FD015
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8769031
PubMed ID	8769031
published in	wds:Q71433378-14F19FDC-BD99-4554-BCFD-7ED626FC8476
published in	The New Zealand Medical Journal
issue	wds:Q71433378-1BDD6B08-934A-4FD9-8D33-ACAEBAA48393
volume	wds:Q71433378-195C9CD4-4EF7-4279-A1D1-75E07C82598D
issue	1024
volume	109
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q71433378
is cites work of	Using thresholds based on risk of cardiovascular disease to target treatment for hypertension: modelling events averted and number treated Statins for primary prevention: at what coronary risk is safety assured? Prediction of mortality from coronary heart disease among diverse populations: is there a common predictive function? Assessment of fracture risk European guidance for the diagnosis and management of osteoporosis in postmenopausal women Guidelines on preventing cardiovascular disease in clinical practice Risk assessment in primary prevention of coronary heart disease: randomised comparison of three scoring methods Zero end-digit preference in recorded blood pressure and its impact on classification of patients for pharmacologic management in primary care - PREDICT-CVD-6 Updated New Zealand cardiovascular disease risk-benefit prediction guide An update on the diagnosis of osteoporosis The current status of primary prevention in coronary heart disease Risk in cardiovascular disease. Merit of using risk reduction rather than absolute risk for lipid lowering drugs New Zealand cardiovascular guidelines: best practice evidence-based guideline: the assessment and management of cardiovascular risk December 2003. 99 mTc-MIBI washout as a complementary factor in the evaluation of idiopathic dilated cardiomyopathy (IDCM) using myocardial perfusion imaging. Effect of inulin-type fructans on blood lipid profile and glucose level: a systematic review and meta-analysis of randomized controlled trials Atherosclerotic Cardiovascular Risk in Japan Simvastatin. A reappraisal of its cost effectiveness in dyslipidaemia and coronary heart disease Use of statins. Sheffield table is useful Assessing heart disease risk in primary care. Cholesterol lowering should be just one part of a multiple risk factor intervention The provision of secondary cardiac prevention measures in a hospital cardiac clinic population and the relationship to psychological variables Dyslipidemia guidelines
is cites work of	wds:Q53253296-D3DF209A-C67F-4EB4-A131-FEC0B780889F wds:Q33825407-17713FF9-7FA4-4E49-AAAB-2857A71A96CD wds:Q35992561-0D4EAFCE-C523-4A1D-B65D-FB492224756D wds:Q33578490-E8BC553F-F727-4EEC-B36D-15AC01F37E1C wds:Q33791530-C1F0A9A0-57E1-4497-B9CC-C21C45CE2FB1 wds:Q33800200-525C9C34-89C1-433A-9F7E-19D029F6BE32 wds:Q35580338-346C5E8E-862C-44C6-814A-B151FB352707 wds:Q42758872-FF75AFAD-FC39-43E6-A313-6CC897451A0C wds:Q33801256-B30F2BDE-5101-4C4C-80A7-B31C15B264E9 wds:Q28362569-101DECBE-47F5-4EDB-9580-8A5CFEAFCBE1 wds:Q35865512-820ABA3A-8DB2-4236-8E09-0E365AF808F2 wds:Q34108843-EE21830B-BB9E-4A5C-A817-5998E41BF973 wds:Q24793532-585F6D14-4A55-40C4-BAE7-47C63C433B2C wds:Q37316430-7E2AEC52-E307-4EB3-936B-AFD864EA49CA wds:Q28192935-06AC178B-DBBD-4FED-BEE9-3B2EA3E291E4 wds:Q36131678-A15C5766-5113-42DA-993F-D6EAEA7E76CE wds:Q36316272-D04B12A2-0A32-42E1-AA79-239234BC2CBD wds:Q37037296-28880CD7-2BC2-4CFD-9E9B-AF08189159D2 wds:Q37316960-F08478DB-2623-4641-9119-AA8BCF8DA90D wds:Q42766542-9ACF2D22-44F0-4104-A0C1-C3013E751849 wds:Q42855613-346BA995-1FA2-4B5F-AC5E-37EBB60824D8

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 194 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software